HARLAN ARH — History
CCN 180050 | 3-year financial timeline | COVID resilience: 9/100
🛡️ Public data only — no PHI permitted on this instance.
$70M
Latest Revenue (FY2022)
-5.5%
Revenue CAGR (3yr)
-24.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $78M | $75M | $70M | -6.7% | -5.5% |
| Operating Expenses | $76M | $84M | $87M | +3.0% | +6.5% |
| Operating Margin | 2.4% | -12.4% | -24.1% | -93.9% | +0.0% |
| Net Income | $2M | $-9M | $-17M | -80.9% | +0.0% |
| Licensed Beds | 81 | 73 | 56 | -23.3% | -16.9% |
| Total Patient Days | 11,539 | 11,250 | 7,306 | -35.1% | -20.4% |
| Medicare Day % | 40% | 31% | 31% | +1.4% | -11.3% |
| Medicaid Day % | 4% | 3% | 3% | +20.6% | -14.8% |
COVID Impact & Recovery
Resilience Score: 9/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -10.7% ($78M → $70M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-5.5%
This Hospital
+7.6%
State Avg
Latest Margin
-24.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $66M | -37.3% |
| FY2024 (proj) | $62M | -50.6% |
| FY2025 (proj) | $57M | -63.8% |